# Safety and Preliminary Efficacy of BGP345A in Constipation Due to Opioid-based Medications

> **NCT05133076** · PHASE2 · COMPLETED · sponsor: **BioGaia Pharma AB** · enrollment: 14 (actual)

## Conditions studied

- Opioid-Induced Constipation

## Interventions

- **BIOLOGICAL:** Lactobacillus gasseri BGP345A
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT05133076
- **Lead sponsor:** BioGaia Pharma AB
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-20
- **Primary completion:** 2024-12-12
- **Final completion:** 2024-12-12
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2025-06-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05133076

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05133076, "Safety and Preliminary Efficacy of BGP345A in Constipation Due to Opioid-based Medications". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05133076. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*